City
Epaper

Plasma therapy dropped from ICMR COVID-19 treatment protocols

By ANI | Updated: May 18, 2021 11:04 IST

The use of convalescent plasma has been dropped from the recommended treatment protocols for COVID-19, according to the latest ...

Open in App

The use of convalescent plasma has been dropped from the recommended treatment protocols for COVID-19, according to the latest guidelines released by the Indian Council of Medical Research (ICMR) on Monday.

Earlier, as per the ICMR advisory on April 22, Convalescent plasma (Off label) was considered only when the following criteria were met:

  • Early moderate disease (preferably within 7 days of symptom onset, no use after 7 days)
  • Availability of high titre donor plasma (Signal to cut-off ratio (S/O) >3.5 or equivalent depending on the test kit being used)

As per the previous advisory, Remdesivir, Tocilizumab (off label) and Convalescent plasma (Off label) were used for treatment of COVID-19 patients.

However, as per the latest advisory, only Remdesivir, Tocilizumab (off label) can be used.

On May 14, a meeting of the ICMR-National Task Force for Covid-19 was held during which its 'ineffectiveness' in a number of cases was discussed.

With the cases surging in the country, there has been a spur in the demand for plasma donors, even as experts raise concerns over the efficacy of plasma therapy for Covid-19 patients.

India's daily spike in coronavirus cases has dipped below the 3 lakh mark for the first time in nearly 26 days as 2,81,386 fresh infections were recorded in the last 24 hours, according to the Union Health Ministry's data on Monday.

The Ministry of Health and Family Welfare reported 4,106 Covid-related new deaths in the country and 3,78,741 fresh recoveries during the 24-hour period. The cumulative caseload stands at 2,49,65,463, including 2,11,74,076 recoveries, 35,16,997 active cases and 2,74,390 deaths.

As per the Indian Council of Medical Research (ICMR), a total of 31,64,23,658 samples have been tested for COVID-19 up to May 16, of these, 15,73,515 samples were tested on Sunday.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Indian Council Of Medical ResearchIcmrPlasma therapyRemdesivirCovid-19Coronavirus
Open in App

Related Stories

MaharashtraHair Loss in Maharashtra Villages: ICMR and AIIMS Collect Samples to Investigate Extreme Hair Fall Condition in Buldhana

NationalWhat Is HMPV? Symptoms and How to Stay Safe During Human Metapneumovirus Outbreak

InternationalHMPV Outbreak: Covid-19-Like Virus Spreading In Malaysia and Hong Kong After China

NationalHMPV Outbreak In India: Second Positive Case Reported In Bengaluru

NationalHMPV Virus Alert: Delhi Health Department Issues Advisory Amid Growing Concerns

National Realted Stories

National'I will say nothing more': US spokesperson shuns Pak journalist's question over Pahalgam attack

NationalTourists who return to Mumbai thank Centre, Maharashtra govt after Pahalgam terror attack

NationalPresident Droupadi Murmu to visit Vatican City for Pope Francis's funeral

NationalHelipad to be built at city bus terminal in Gurugram

NationalInfant dies after accidentally drinking chemical in Gurugram village